APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6244-6251

  Warren, T L ^a   Bhatia, S K ^a   Acosta, A M ^a   Dahle, C E ^a   Ratliff, T L ^a   Krieg, A M ^a   Weiner, G J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CPG ISLAND; DENDRITIC CELL; HELPER CELL; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0034547841     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6244     Document Type: Article

References (53)

1. CpG motifs in bacterial DNA trigger direct B-cell activation
2. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
3. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
4. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides
5. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-γ production in cells from allergic individuals and inhibit IgE synthesis in vitro
6. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
7. DNA from bacteria, but not vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth
8. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
9. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
10. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
11. CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen
12. Cpg oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
13. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor
14. From dendritic cells to tumour vaccines
15. Dendritic cells hold promise for immunotherapy
16. Immunotherapy using dendritic cells picks up steam
17. Dendritic cells and immune-based therapies
18. Enhanced immunogenicity of tumor-specific immunoglobulin-pulsed dendritic cells using a chimeric idiotype-GM-CSF fusion protein
19. Peptide-pulsed dendritic ceils induce antigen-specific, CTL-mediated protective tumor immunity
20. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured-in vitro from bone marrow precursors can provide against tumor challenge
21. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
22. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: A feasibility study
23. + T cells mediate CD40-independent maturation of dendritic cells in vivo
24. Induction of antitumor immunity using bone marrow-generated dendritic cells
25. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
26. + T cell help
27. + T-helper and a T-killer cell
28. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
29. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
30. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
31. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
32. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
33. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells
34. T cell receptor antagonist peptides induce positive selection
35. Interleukin-12, an integral cytokine in the immune response
36. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses
37. IL-12-deficient mice are detective in IFNγ production and type 1 cytokine responses
38. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
39. Control of syngeneic tumor growth by activation of CD8+ T cells: Efficacy is limited by migration away from the site and induction of nonresponsiveness
40. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
41. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
42. Rapid immune activation by CpG motifs in bacterial DNA: Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway
43. The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy
44. + cytotoxic T lymphocytes
45. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells
46. Oligodeoxynucleotides containing palindrome sequences with internal 5'- CpG-3' act directly on human NK and activated T cells to induce IFN-γ production in vitro
47. Exact prediction of a natural T cell epitope
48. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses
49. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism
50. + T cells
51. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-γ production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type 1 and interleukin-12
52. Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
53. Interleukins 18 and 12 synergistically upregulate interferon-γ production by murine dendritic epidermal T cells